Healthcare technology company Cue Health (Nasdaq: HLTH) announced that it has been awarded a contract worth approximately $28 million by the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS). The contract is aimed at developing a molecular multiplex test for Flu A/B, RSV, and COVID-19 […]
Sorrento Therapeutics has acquired a majority stake in Zhengzhou Fortune Bioscience (Zhengzhou FortuneBio), a Chinese diagnostic manufacturer, for an undisclosed price. According to Sorrento Therapeutics, the acquisition is in response to drastic increasing demands around the world and planned product build-up expecting possible additional approvals for its COVISTIX Covid-19 virus rapid antigen detection test. Zhengzhou […]
API Holdings Ltd, the holding company for Indian online pharmacy store PharmEasy, has agreed to acquire a stake of 66.1% in Thyrocare Technologies, a chain of diagnostic and preventive care laboratories, for Rs 45.46 billion ($61.25 million). The stake is being acquired from Dr. A Velumani and affiliates at a price of INR 1,300 per […]